Forma Therapeutics Holdings Inc.

7.23+0.2000+2.84%Vol 368.55K1Y Perf -73.02%
Jun 27th, 2022 16:00 DELAYED
BID6.90 ASK7.76
Open6.96 Previous Close7.03
Pre-Market- After-Market7.23
 - -  - -%
Target Price
38.67 
Analyst Rating
Strong Buy 1.00
Potential %
434.86 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     56.86
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
10.39 
Earnings Rating
Market Cap345.62M 
Earnings Date
12th Aug 2022
Alpha-0.08 Standard Deviation0.14
Beta0.44 

Today's Price Range

6.767.29

52W Range

4.9526.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
23.55%
1 Month
23.12%
3 Months
-21.36%
6 Months
-52.66%
1 Year
-73.02%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FMTX7.230.20002.84
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Earnings HistoryEstimateReportedSurprise %
Q01 2022-1.04-0.9310.58
Q04 2021-0.94-1.06-12.77
Q03 2021-0.96-0.915.21
Q02 2021-0.79-0.92-16.46
Q01 2021-0.73-0.76-4.11
Q04 2020-0.79-0.6813.92
Q03 2020-0.65-0.67-3.08
Q02 2020-0.59-4.58-676.27
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date12th Aug 2022
Estimated EPS Next Report-0.97
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume368.55K
Shares Outstanding47.80K
Shares Float30.00M
Trades Count4.56K
Dollar Volume2.63M
Avg. Volume836.68K
Avg. Weekly Volume987.06K
Avg. Monthly Volume902.85K
Avg. Quarterly Volume620.14K

Forma Therapeutics Holdings Inc. (NASDAQ: FMTX) stock closed at 7.03 per share at the end of the most recent trading day (a -2.9% change compared to the prior day closing price) with a volume of 1.11M shares and market capitalization of 345.62M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 80 people. Forma Therapeutics Holdings Inc. CEO is Frank D. Lee.

The one-year performance of Forma Therapeutics Holdings Inc. stock is -73.02%, while year-to-date (YTD) performance is -50.56%. FMTX stock has a five-year performance of %. Its 52-week range is between 4.95 and 26.9, which gives FMTX stock a 52-week price range ratio of 10.39%

Forma Therapeutics Holdings Inc. currently has a PE ratio of -1.50, a price-to-book (PB) ratio of 0.59, a price-to-sale (PS) ratio of 203.83, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -31.11%, a ROC of -32.52% and a ROE of -33.62%. The company’s profit margin is -%, its EBITDA margin is -1 559.60%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Forma Therapeutics Holdings Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.97 for the next earnings report. Forma Therapeutics Holdings Inc.’s next earnings report date is 12th Aug 2022.

The consensus rating of Wall Street analysts for Forma Therapeutics Holdings Inc. is Strong Buy (1), with a target price of $38.67, which is +434.86% compared to the current price. The earnings rating for Forma Therapeutics Holdings Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Forma Therapeutics Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Forma Therapeutics Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 18.98, ATR14 : 0.57, CCI20 : 207.34, Chaikin Money Flow : 0.15, MACD : -0.01, Money Flow Index : 70.42, ROC : 13.75, RSI : 60.33, STOCH (14,3) : 83.20, STOCH RSI : 0.89, UO : 60.82, Williams %R : -16.80), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Forma Therapeutics Holdings Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
6 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Forma Therapeutics Holdings Inc.

Forma Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. The firm's pipeline products are FT-4202, FT-7051, FT-8225, and others.

CEO: Frank D. Lee

Telephone: +1 617 679-1970

Address: 500 Arsenal Street, Watertown 02472, MA, US

Number of employees: 80

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

Bearish Bullish

69%31%

TipRanks News for FMTX

Fri, 27 May 2022 12:45 GMT Forma Therapeutics Holdings (FMTX) Receives a Buy from SVB Securities

- TipRanks. All rights reserved.

News

Stocktwits